Cita APA

Cescon, D., Hilton, J., Morales, S., Layman, R., Pluard, T., Yeo, B., & Oliveira, M. (2024). A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.

Citación estilo Chicago

Cescon, David, John Hilton, Serafin Morales, Rachel Layman, Timothy Pluard, Belinda Yeo, y Mafalda Oliveira. A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer. 2024.

Cita MLA

Cescon, David, et al. A Phase I/II Study of GSK525762 Combined With Fulvestrant in Patients With Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer. 2024.